Investor Relations represents MorphoSys and its equity story to the financial market and supports the Company's overall strategic communication. Through active and transparent investor relations work, the aim is to enable investors to make an informed decision of the Company.
06
Sep
2022
Commerzbank and ODDO BHF - Corporate Conference (Frankfurt, Germany)
07
Sep
2022
Citi's 17th Annual BioPharma Conference (Boston, USA)
13
Sep
2022
Morgan Stanley 20th Annual Global Healthcare Conference (New York, USA)
Financial Information
Take a closer look at our Financial Guidance 2022 and the Fundamentals of MorphoSys.
Annual General Meeting
The virtual Annual General Meeting 2022 of MorphoSys AG.
Stock Information
MorphoSys stock information in detail.
Corporate Governance
We believe that our commitment to high Corporate Governance standards will ultimately increase shareholder value.
Our Understanding of Sustainability
We are conscious of the responsibility we share for present and future generations and see sustainable action as a prerequisite for long-term business success.
You are now leaving the MorphoSys.com website. This link will take you to a different website. You are solely responsible for your interactions with that website.
Do you wish to proceed ?
